Attached files
file | filename |
---|---|
8-K - 8-K - Benitec Biopharma Inc. | d925242d8k.htm |
Exhibit 16.1
June 5, 2020
US Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Benitec Biopharma Inc
File No. 001-39267
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Benitec Biopharma Inc. dated June 5, 2020 and are in agreement with the statements contained solely as it relates to our Firm.
Very truly yours,
/s/ GRANT THORNTON AUDIT PTY LTD |
Sydney, NSW Australia |
June 5, 2020 |